MAA
CVS icon

Mraz Amerine & Associates’s CVS Health CVS Stock Holding History

Mraz Amerine & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,643
Closed -$1.3M – 167
2024
Q3 		$1.3M Buy
20,643
+2,022
+11% +$118K 0.23% 69
2024
Q2 		$1.1M Buy
18,621
+6,473
+53% +$405K 0.23% 73
2024
Q1 		$969K Buy
12,148
+545
+5% +$41.6K 0.18% 81
2023
Q4 		$916K Sell
11,603
-130
-1% -$9.25K 0.19% 84
2023
Q3 		$819K Buy
11,733
+2,112
+22% +$150K 0.18% 82
2023
Q2 		$665K Buy
9,621
+298
+3% +$21.2K 0.16% 93
2023
Q1 		$693K Buy
9,323
+880
+10% +$73.8K 0.17% 92
2022
Q4 		$787K Sell
8,443
-60
-0.7% -$5.79K 0.19% 80
2022
Q3 		$811K Buy
8,503
+202
+2% +$20K 0.22% 76
2022
Q2 		$769K Hold
8,301
– – 0.2% 79
2022
Q1 		$840K Hold
8,301
– – 0.2% 82
2021
Q4 		$856K Hold
8,301
– – 0.22% 74
2021
Q3 		$704K Hold
8,301
– – 0.19% 82
2021
Q2 		$693K Sell
8,301
-100
-1% -$8.19K 0.19% 80
2021
Q1 		$632K Sell
8,401
-839
-9% -$61.1K 0.18% 82
2020
Q4 		$631K Sell
9,240
-280
-3% -$18.2K 0.21% 72
2020
Q3 		$556K Buy
+9,520
New +$592K 0.21% 68

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mraz Amerine & Associates's CVS Position: Q4 2024 in Review

Mraz Amerine & Associates sold out of CVS Health (CVS) in Q4 2024, closing a stake of 20,643 shares — an estimated $1.3M sold.

Mraz Amerine & Associates first reported a position in CVS in Q3 2020 and held it in 17 quarters. The position peaked at $1.3M in Q3 2024. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Mraz Amerine & Associates reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Mraz Amerine & Associates sold 20,643 CVS Health shares in Q4 2024, an estimated $1.3M.
  • Mraz Amerine & Associates first reported a position in CVS Health in Q3 2020 and held it in 17 quarters.
  • Mraz Amerine & Associates's CVS Health position peaked at $1.3M in Q3 2024.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Mraz Amerine & Associates's 13F filing for Q4 2024, filed 31 Jan 2025.